Filing Details
- Accession Number:
- 0001567619-21-018515
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-10-21 08:47:14
- Reporting Period:
- 2021-10-18
- Accepted Time:
- 2021-10-21 08:47:14
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1815903 | Petros Pharmaceuticals Inc. | PTPI | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1208886 | D John Shulman | 1185 Avenue Of The Americas, 3Rd Floor New York NY 10036 | Yes | No | Yes | No | |
| 1835386 | Jcp Iii Sm Aiv, L.p. | 1185 Avenue Of The Americas, 3Rd Floor New York NY 10036 | No | No | Yes | No | |
| 1835421 | Juggernaut Partners Iii Gp, L.p. | 1185 Avenue Of The Americas, 3Rd Floor New York NY 10036 | No | No | Yes | No | |
| 1835433 | Juggernaut Partners Iii Gp, Ltd. | 1185 Avenue Of The Americas, 3Rd Floor New York NY 10036 | No | No | Yes | No | |
| 1836319 | Metp Holdings Llc | 1185 Avenue Of The Americas, 3Rd Floor New York NY 10036 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $0.0001 Per Share | Acquisiton | 2021-10-18 | 1,661,807 | $1.72 | 5,057,771 | No | 4 | P | Indirect | See Footnote |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | See Footnote |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Warrant | Acquisiton | 2021-10-18 | 1,661,807 | $0.00 | 1,661,807 | $1.72 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 1,661,807 | 2021-10-18 | 2026-10-18 | No | 4 | P | Indirect |
Footnotes
- See Note (1) in Exhibit 99.1.
- Includes 185,414 shares of Common Stock previously held of record by Metuchen Therapeutics, LLC ("MT") that were received by JCP III SM AIV, L.P. as a liquidating distribution. In prior reports, the reporting persons beneficially owned the 185,414 previously held by MT.
Billionaire Hedge Funds
